Benjamin Cher

Benjamin Cher

CORRESPONDENT

Benjamin is a correspondent with BT’s Companies and Markets team. He covers the tech and venture capital ecosystem in Southeast Asia. He was previously with Garage, BT’s startup and venture capital portal, and The Edge Singapore.

GXS Bank, MariBank and Trust Bank have issued credit cards in an effort to engage customers on a more regular basis.

Singapore digital banks want more than just your deposits; credit cards are the next battleground

2026-08-28T02:23:03.000Z
Senior managing partner Jenny Lee says taking on new partners enhances Granite Asia’s ability to offer comprehensive financing.

Granite Asia exceeds US$500 million target for pan-Asia private credit fund

2026-08-25T12:54:57.000Z
UltraGreen.ai has about 83% of ICG dye market share in the US, says Jamal Aliyev, an independent analyst.

UltraGreen.ai faces new competition in US market, possible pricing pressure

2026-08-19T07:53:50.000Z
Monee is emerging as a key driver of incremental profitability for Sea, and could match or surpass Shopee’s adjusted Ebitda contribution over the longer term, says CGS’ Jacquelyn Yow.

Grab, Sea see loan books surge in Q2 as financial services drive growth

2026-08-18T03:57:26.000Z
The GXS Credit Card is different from GXS FlexiCard, with a minimum income requirement of S$30,000 per year to qualify.

GXS enters credit card arena with new cashback card

2026-08-17T06:26:54.000Z
Creators are more trusted here in Apac than anywhere else in the world, says Benjamin Joe, vice-president, Apac at Meta.

Meta leans into creator-led commerce in Apac

2026-08-13T13:10:45.000Z
ST Engineering’s H1 revenue is up 11.1% at S$6.57 billion, from S$5.92 billion a year earlier.

ST Engineering H1 net profit rises 27.1% to S$512.1 million on strong segment growth

2026-08-13T00:05:55.000Z
Shopee, Sea’s e-commerce arm, reports a 48.2% increase in revenue to US$5.6 billion in Q2.

Sea Q2 earnings up 10.6% at US$458.1 million as Shopee hits new highs

2026-08-11T12:02:18.000Z
There is intensifying competition in the biotech space, but Huang believes that K2 Therapeutics’ hub-and-spoke model should give it the edge.

Singapore-based biotech K2 Therapeutics secures US$50 million seed round; appoints Huang Ying as CEO

2026-08-11T12:00:00.000Z
The biotech industry is in its own microcosm, unaffected by geopolitics, says Peter Kash, executive chairman of Camelot BioCapital.

Biotech transcends geopolitics as family offices fuel next wave of innovation: Camelot BioCapital’s Peter Kash

2026-08-10T23:00:00.000Z